Getinge Group: Resolutions at Getinge’s Annual General Meeting

  Getinge Group: Resolutions at Getinge’s Annual General Meeting

Business Wire

GETINGE, Sweden -- March 21, 2013

Regulatory News:

At the Annual General Meeting of Getinge AB held on 21 March 2013, the
following was resolved.

Election of Board of Directors Carl Bennet (Chairman), Johan Bygge, Cecilia
Daun Wennborg, Carola Lemne, Johan Malmquist, Johan Stern and Maths Wahlström
were re-elected as members of the Board.

Fees to the Board of Directors It was resolved that remuneration to the Board
of Directors shall amount to a total of SEK 3,675,000 excluding remuneration
for Committee work, of which SEK 1,050,000 to the Chairman and SEK 525,000 to
each of the other Board members elected by the Meeting who are not employees
of Getinge Group. In addition hereto, the Meeting resolved that work in the
Audit Committee shall be compensated with SEK 240,000 to the Chairman and SEK
120,000 to each of the other members, while work in the Remuneration Committee
work shall be compensated with SEK 125,000 to the Chairman and SEK 92,000 to
each of the other members.

Dividend In accordance with the proposal of the Board of Directors and the
CEO, the Annual General Meeting resolved to declare a dividend of SEK 4.15 per
share. Tuesday 26 March 2013 was determined as record date for dividend.

Guidelines for Remuneration to Senior Executives The Annual General Meeting
approved the proposal of the Board regarding guidelines for remuneration to
senior executives, which principally involve the following. Remuneration and
other terms and conditions of employment for senior executives shall be based
on market conditions and be competitive in all markets where Getinge operates,
to ensure that competent and skillful employees can be attracted, motivated
and retained. The total remuneration to senior executives shall comprise basic
salary, variable remuneration, pensions and other benefits. The variable
remuneration shall be limited and connected to predetermined and measurable
criteria elaborated with the purpose to promote the long-term added value of
the company. The Board shall retain the right to deviate from the guidelines
if motivated by particular reasons on an individual basis.

GETINGE GROUP is a leading global provider of products and systems that
contribute to quality enhancement and cost efficiency in healthcare, care and
research. We operate under the three brands of ArjoHuntleigh, GETINGE and
MAQUET. ArjoHuntleigh focuses on patient mobility and wound management
solutions. GETINGE provides solutions for infection control in healthcare and
contamination prevention in biotechnology. MAQUET specializes in solutions,
therapies and products for surgical interventions and intensive care.

Getinge AB discloses the information herein in accordance with the Swedish
Securities Market Act and/or the Financial Instruments Trading Act. The
information was submitted for publication on 21 March 2013 at 5 PM CET.

This information was brought to you by Cision


Johan Malmquist
CEO, Getinge Group
Tel: +46 10 335 55 33
Ulf Grunander
CFO, Getinge Group
Tel: +46 10 335 55 80
Press spacebar to pause and continue. Press esc to stop.